The global Endoscopic
Retrograde Cholangiopancreatography (ERCP) market is foreseen to grow at 8.1%,
from USD 1.35 Billion in 2021 to USD 2.54 Billion in 2029. Rising incidence of
cancer, increasing investments, funds, and grants by governments and healthcare
organizations to improve endoscopy research, growing focus on investments by
hospitals for advanced endoscopy instruments are the factors to grow the global
endoscopic retrograde cholangiopancreatography (ERCP) market. However, high
costs of endoscopic retrograde cholangiopancreatography devices, development of
other procedures like EUS and MRCP is seen restraint the market growth for the
estimated period.
Market Definition
What is Endoscopic
Retrograde Cholangiopancreatography (ERCP)?
Endoscopic
retrograde cholangiopancreatography (ERCP) is a procedure to diagnose and treat
problems in the pancreas, liver, bile ducts, and gallbladder. It is a combination
of X-ray and the upper gastrointestinal (GI) endoscope used for the diagnosis of
such problems.
Market Overview
The
endoscopic retrograde cholangiopancreatography (ERCP) market search
study helps to thoroughly understand the current trend in the market
competitive analysis of the players in the emerging market. Moreover, the DRO
in the endoscopic retrograde cholangiopancreatography (ERCP) market offers
valuable perspicuity and a current scenario for making the right decision. The
research study covers the eminent players in the market with a detailed
analysis of the company and a financial overview containing their net sales,
business mix and geographical reach It mainly focuses on the key developments
of the products/services offered by the company in recent years. Besides, we at
Zettabyte have the expertise to analyses the global endoscopic retrograde
cholangiopancreatography (ERCP) market player's competitive landscape helping
the client comprehend their specific strategic growth approaches.
Endoscopic
retrograde cholangiopancreatography (ERCP) market study by "Zettabyte
Analytics" offers details about the market scope, market segmentation,
technological advancement in the Endoscopic retrograde cholangiopancreatography
(ERCP) market and highlights the optimistic, competitive landscape and trends
enduring over the years.
Major players in
the endoscopic retrograde cholangiopancreatography (ERCP) market Ambu A/S, B.
Braun Melsungen AG, Boston Scientific Corporation, Changzhou Health Microport
ME, Conmed Corporation, Cook Medical, Fujifilm Holdings Corporation, Hobbs
Medical, Inc., Hoya Corporation, Huger Medical Instrument Co., Intromedic Co.,
Ltd., Johnson & Johnson,Karl Storz Se & Co. KG, Medi-Globe GmbH,
Medtronic, Plc, Merit Medical Systems, Inc., Olympus Corporation, Sonoscape
Medical Corp., Steris Plc, Taewoong Medical Co., Ltd., Telemed Systems, Inc.
COVID-19 Impact on Global Endoscopic
retrograde cholangiopancreatography (ERCP) market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. The impact of COVID-19 on the endoscopic retrograde
cholangiopancreatography (ERCP) market has forced the companies to change their
sourcing, pricing, and promotion strategies. The endoscopic retrograde
cholangiopancreatography (ERCP) market players are seen focusing more on
optimizing the E-commerce networks with the rising innovations in the digital
sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). The market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and endoscopic retrograde
cholangiopancreatography (ERCP) market future markets are analyzed to
understand their impact on demand for the forecast period. Growth rates have
been estimated using correlation, regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global endoscopic retrograde cholangiopancreatography
(ERCP) market segmented on the basis of product type, procedure, end user and
region:
Product Type Outlook:
On the basis of
product type, the market is segmented into endoscopes, endotherapy devices,
energy devices, visualization systems, others.
Figure 1 Endoscopic Retrograde
Cholangiopancreatography (ERCP) Market By Product Type (Market Size And
Forecast By Value - USD Million, 2021 & 2029)